Abstract
Risk management (RM) is an ongoing systematic approach which tends to predict future problems facing any product development process by analyzing loops of gathered or stored data and communicating their impact to enable design decision-making. It identifies problems, analyzes data, models and implements solutions and performs ongoing monitoring to assure that the corrective and/or preventive actions are being considered. As the majority of medical devices are monitoring devices, data communication and analysis play a crucial role in predicting the effectiveness and safety of a device. Device related data, patient related data and device-patient related data are great sources for enhancing either new designs or improving already existing ones. Analyzing such data can provide researchers and device development teams with a complete justification and patterns of interest about performance, life and safety. This paper introduces a review of the existing patents in the field of medical devices RM procedures, techniques and technologies as a mandatory requirement by the Food and Drug Administration (FDA) regarding the device approval and marketing. The paper focuses on the body of literature during three main stages of the device lifecycle; the design stage, the manufacturing stage and the device- user interface stage. The aim is to highlight major practices and their similarities as well as differences and future expectations for medical device risk assessment techniques. The authors use this study to guide the establishing of a new technique to quantify risk at the early design stage using device performance data under the umbrella of the RM procedure.
Keywords: Medical devices, regulatory system, risk assessment, risk management, validation and safety, verification.
Recent Patents on Engineering
Title:Recent Patents on Risk Management During Medical Device Lifecycle "Managing the Transition From Bench to Market"
Volume: 8 Issue: 2
Author(s): Ilham H. Ibrahim and Constantin Chassapis
Affiliation:
Keywords: Medical devices, regulatory system, risk assessment, risk management, validation and safety, verification.
Abstract: Risk management (RM) is an ongoing systematic approach which tends to predict future problems facing any product development process by analyzing loops of gathered or stored data and communicating their impact to enable design decision-making. It identifies problems, analyzes data, models and implements solutions and performs ongoing monitoring to assure that the corrective and/or preventive actions are being considered. As the majority of medical devices are monitoring devices, data communication and analysis play a crucial role in predicting the effectiveness and safety of a device. Device related data, patient related data and device-patient related data are great sources for enhancing either new designs or improving already existing ones. Analyzing such data can provide researchers and device development teams with a complete justification and patterns of interest about performance, life and safety. This paper introduces a review of the existing patents in the field of medical devices RM procedures, techniques and technologies as a mandatory requirement by the Food and Drug Administration (FDA) regarding the device approval and marketing. The paper focuses on the body of literature during three main stages of the device lifecycle; the design stage, the manufacturing stage and the device- user interface stage. The aim is to highlight major practices and their similarities as well as differences and future expectations for medical device risk assessment techniques. The authors use this study to guide the establishing of a new technique to quantify risk at the early design stage using device performance data under the umbrella of the RM procedure.
Export Options
About this article
Cite this article as:
Ibrahim H. Ilham and Chassapis Constantin, Recent Patents on Risk Management During Medical Device Lifecycle "Managing the Transition From Bench to Market", Recent Patents on Engineering 2014; 8 (2) . https://dx.doi.org/10.2174/1872212108666140829011303
DOI https://dx.doi.org/10.2174/1872212108666140829011303 |
Print ISSN 1872-2121 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4047 |
Call for Papers in Thematic Issues
Computational Information Processing and Edge Computing
The rapid evolution of computational information processing and edge computing has transformed numerous industries, enabling more efficient data processing, real-time analytics, and intelligent decision-making at the edge of networks. This special issue aims to gather cutting-edge research, innovative methodologies, and practical applications in these dynamic fields. We invite contributions that ...read more
Development of Oceanic Engineering based on Radar/Sonar/optical Technology
Radar, sonar and optical devices are the most common devices for oceanic engieering. The exploration and development of marine resources, communication and navigation, underwater target detection and recognition, environmental monitoring and natural disaster prediction all depend on oceanic engineering technology based on radar, sonar and optical technology. The development of ...read more
Industry 4.0 Driven Techniques in Engineering for Sustainability and Innovations
The advent of Industry 4.0 (fourth Industrial Revolution) in the realm of engineering has sparked a digital revolution in sustainability and innovations. The techniques such as artificial intelligence (AI), Digital Twin (DT), Cyber-Physical Systems (CPS), Internet of Things (IoT), cloud computing, additive manufacturing, human-machine interaction (HMI) etc. has reshaped the ...read more
New Frontiers of Artificial Intelligence and Emerging Technologies
The rapid advancements in artificial intelligence (AI) and emerging technologies are charting new frontiers, revolutionizing various sectors, and transforming how we interact with the world. AI's integration with innovative technologies like quantum computing, blockchain, and the Internet of Things (IoT) is creating unprecedented opportunities and challenges. These synergies are not ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Demonstration of the Efficacy of Statins in Resolution of Plaque Inflammation by Serial FDG Imaging
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints
Current Medicinal Chemistry Cytokines in Systemic Lupus Erythematosus
Current Molecular Medicine Empowering Translational Research in Fetal Growth Restriction: Sheep and Swine Animal Models
Current Pharmaceutical Biotechnology Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
Current Drug Targets COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice
Infectious Disorders - Drug Targets Re-Balancing of Inflammation and Aβ Immunity as a Therapeutic for Alzheimers Disease-View from the Bedside
CNS & Neurological Disorders - Drug Targets Bidirectional Nature of Cardiovascular and Kidney Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data
Current Medicinal Chemistry Lifelong Endocrine Fluctuations and Related Cognitive Disorders
Current Pharmaceutical Design Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry Clinical Aspects and Therapeutic Perspectives of Relaxin
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases
Current Medicinal Chemistry Chondroitin Sulfate and Sulfur Containing Chondroprotective Agents: Is there a Basis for their Pharmacological Action?
Current Rheumatology Reviews Pertinence of Apoptosis Markers for the Improvement of In Vitro Fertilization (IVF)
Current Medicinal Chemistry What Metabolic Syndrome Contributes to Brain Outcomes in African American & Caucasian Cohorts
Current Alzheimer Research Resistin and Oxidative Stress as Markers of Atherosclerosis in Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Biological Treatments for SAPHO Syndrome: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Human Skeletal Muscle Aging and the Oxidative System: Cellular Events
Current Aging Science Cholesterol Ester Transfer Protein (CETP), Postprandial Lipemia and Hypolipidemic Drugs
Current Medicinal Chemistry